For the first nine months of 2018, US GAAP operating loss amounted to CHF 271 million and non-GAAP operating loss amounted to CHF 247 million. US GAAP operating loss was based on revenues of CHF 20 million, non-GAAP R&D expenses of CHF 227 million, non-GAAP G&A expenses of CHF 39 million, depreciation and amortization of CHF 14 million, and share-based compensation of CHF 10 million.

The US GAAP net loss amounted to CHF 278 million resulting in a net loss per share of CHF 2.27.

 

Idorsia's key numbers

 Nine months 2018  Third quarter 2018

(in CHF millions, except EPS)

US GAAP Non-GAAP US GAAP

Non-GAAP

Revenues

20

20

7

7

Operating expenses

(290)

(266)

(122)

(114)

Operating income (loss)

(271)

(247)

(115)

(107)

Net income (loss)

(278)

(249)

(119)

(109)

Basic EPS

(2.27)

(2.03)

(0.92)

(0.84)

Basic number of shares (weighted average)

122.7

122.7

129.6

129.6

Diluted EPS

(2.27) (2.03) (0.92)

(0.84)

Diluted number of shares (weighted average)

122.7 122.7 129.6

129.6

Idorsia measures, reports and issues guidance on non-GAAP operating performance. Idorsia believes that these non-GAAP financial measurements more accurately reflect the underlying business performance and therefore provide useful supplementary information to investors. These non-GAAP measures are reported in addition to, not as a substitute for, US GAAP financial performance.

Financial Guidance

“Our financial guidance for 2018 remains unchanged, unforeseen events and potential milestone expenses excluded, we expect non-GAAP operating expenses for 2018 to be around 390 million Swiss francs. With this level of investment and the new cash raised, we are confident that we can develop our late-stage pipeline through to completion, so that we know the true potential of our assets and make strategic decisions on how to commercialize them.”

André Muller
Chief Financial Officer

Financial Charts - 9 months

Financial charts for the first nine months of 2018 are presented in the company presentation.